Do not use in animals with known hypersensitivity to the active substance.
Special precautions to be taken by the person administering the veterinary medicinal product to the animal
When using do not eat, drink or smoke. After use, wash any contaminated skin immediately with soap and clean water. This product contains clenbuterol, a beta-agonist. Accidental self-injection may cause tachycardia and tremor. These effects may be reversed by the use of a non-selective beta-blocker. If accidental self-injection occurs seek medical advice immediately, avoiding driving if possible.
Clenbuterol decreases the tonus of the uterine muscles. Pregnant women should avoid any risk of exposure to Planipart and should not administer the product.
This product is indicated for use during the early (embryo transfer) or the final stages of pregnancy as well as during labour. The use of the product has not been shown to adversely affect the viability of the new-born animal nor the normal course of the post partum period including subsequent fertility. In case of lactation the withdrawal time for milk has to be considered.
Not to be used in conjunction with atropine.
Not to be used with general anesthesia because of the possible hypotensive effects.
Antagonistic to the effects of prostaglandin F2α and oxytocin.
The product is a β-adrenergic stimulant and is therefore antagonised by β-blocking agents. In order to prevent additive effects, the product should not be given with other sympathomimetics or vasodilators.
In case of accidental overdosage a β-blocker, such as propranolol, may be used as antidote.
Withdrawal Periods
Meat and Offal : 14 days.
Milk: 60 hours.